What can you say

Words you can't use in healthcare marketing

Not a word list, a claim-type inventory, generated from the live ruleset library. Each family names the law that bans it.

There is no single banned-words list, and any page that gives you one is selling a shortcut that does not exist. What the law actually bans are claim types: cures and guarantees, unsubstantiated success rates, establishment claims like clinically proven, safety absolutes, and inducements to enter treatment. Below is the working inventory the scanner reads for, grouped by family, each tied to the statute that puts it off-limits.

Stop 1The families, and the law behind each

Grouped from the 87 compiled banned-claim rules that apply to addiction and treatment marketing across the federal layer and the states with a live pack. The scanner reads your copy for the claim, not the keyword, so context matters: "no quick cures" passes, "our cure for addiction" flags.

Other verticals carry their own inventories: med spas add establishment-claim and free-offer rules, dental adds board-specific advertising limits, and cannabis adds mandatory warnings. The families above are the addiction and treatment set, which is the deepest.

Stop 2A line that flags, a line that passes

The cure family is the one every writer trips on. Here is the difference the scanner sees.

High riskWould flag
Our program guarantees your recovery from addiction, for good.

A promise of cure or a guaranteed outcome for substance use disorder. Outcomes cannot be guaranteed, and the claim is unsubstantiated on its face.

Cure and guarantee claims · State UDAP and treatment-marketing acts; FTC Act

PassWould clear
Our program gives people the tools and the support to build lasting recovery.

Describes the service and the support without promising a guaranteed result.

Compiled from

  • 18 U.S.C. 220; United States v. Schena, No. 23-2989 (9th Cir. July 11, 2025) (primary anchor); D.N.J. guilty pleas of Sept. 15, 2020 (Mohammad and Dickau) (secondary anchor); Tex. H&S Code 164.005 (state-conditional, TX facets); N.Y. MHL 32.06 (state-conditional, NY facets); Cal. HSC 11831.6 (state-conditional, CA); C.R.S. 12-245-224(1)(q) (CO carve-out divergence caution)
  • FTC Health Products Compliance Guidance (Dec. 2022), competent and reliable scientific evidence standard; 15 U.S.C. 45(a)(1). https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance
  • FTC Health Products Compliance Guidance (Dec. 2022), endorsement substantiation; 16 CFR 255.3; 15 U.S.C. 45(a)(1). https://www.law.cornell.edu/cfr/text/16/part-255
  • 15 U.S.C. 52(a); 15 U.S.C. 45(a)(1); FTC Health Products Compliance Guidance (Dec. 2022), disease claims. https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title15-section52&num=0&edition=prelim
  • 15 U.S.C. 45(a)(1); FTC Health Products Compliance Guidance (Dec. 2022), substantiation of efficacy claims. https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title15-section45&num=0&edition=prelim
  • FTC Health Products Compliance Guidance (Dec. 2022), safety claims; 15 U.S.C. 45(a)(1); 15 U.S.C. 52(a). https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance
  • FTC Health Products Compliance Guidance (Dec. 2022), safety claims; 15 U.S.C. 45(a)(1). https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance
  • FTC Health Products Compliance Guidance (Dec. 2022), substantiation of efficacy claims; 15 U.S.C. 45(a)(1). https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance